XM无法为美国居民提供服务。

Clariant cuts sales target on weak catalyst business, shares fall



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Clariant cuts sales target on weak catalyst business, shares fall</title></head><body>

Writes through to add sales outlook, details on catalysts business, share reaction and analyst comment

By Chiara Holzhaeuser and Antonis Pothitos

July 30 (Reuters) -Shares in Clariant CLN.S fell 7.5% on Tuesday after the Swiss speciality chemicals maker lowered its full-year sales forecast due to a weak performance in its catalysts unit, overshadowing a hike in its margin target.

Clariant expects its sales to be flat or grow by up to a low single-digit percentage this year. Growth in its Adsorbents & Additives unit and its Care Chemicals arm, which includes the newly acquired Lucas Meyer, is expected to compensate for uncertainties in the catalyst business, it said.

The group had originally guided for low single-digit percent sales growth in local currency.

"Investors probably didn't like the weak performance of the catalyst business and the lowered sales guidance," Kepler Cheuvreux analyst Christian Faitz said.

Sales in the catalysts division, which provides catalytic solutions for the chemical industry, fell by 18% in local currency to 222 million Swiss francs ($250.5 million) in the second quarter, hit by declines across its segments.

Clariant said the unit's volumes fell from a year earlier "due to the project nature of the business", while pricing remained stable.

While Clariant expects the overall inflationary environment to continue to ease, it said it does not anticipate a broad market recovery in the second half of the year.

"Our expectation moving forward is for raw materials (prices) to slightly sequentially increase," CEO Conrad Keijzer said during a conference call. For the whole year, raw material costs should still be 7% lower than in 2023, he added.

The company raised its 2024 core profit (EBITDA) margin forecast to around 16% from around 15% previously.

Its EBITDA margin rose to 16.4% in the first half of the year, aided by lower raw material and energy costs and a reduced impact from the closing of its Sunliquid bioethanol production in Romania.

($1 = 0.8861 Swiss francs)



Reporting by Chiara Holzhaeuser and Antonis Pothitos in Gdansk; Editing by Milla Nissi

</body></html>

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明